Biopharma is a regional Middle East pharmaceutical company, specialized in niche and biotech pharmaceutical products with a dedication to providing high-quality products, and meeting unmet patients’ needs. The company has established multiple presences in the middle east to treat rare, life-threatening genetic diseases such as Cystic fibrosis (CF), Mucopolysaccharidosis (MPS), Phenylketonuria (PKU), neuronal ceroid lipofuscinosis typ2 (CLN2), Sickle Cell disease (SCD), Hemophilia and more. Biopharma has a robust presence in the infectious diseases market with the curative medications for the Hepatitis C Virus (HCV) and other breakthrough medicines to prevent and treat serious diseases including Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV). 

The company has founded in 2007 in Dubai, UAE, Biopharma is strategically located in the Middle East, where we have established partnerships with many local distributors and wholesalers to ensure reaching out as many patients as possible, and build strong relationships across all levels of the healthcare system. The company is committed to providing our customers with the best possible healthcare solutions that close the care gap, with a deep understanding of national and regional needs. For company updates and to learn more about Biopharma, visit www.biopharma-mea.com or follow us on Facebook, Twitter, LinkedIn, and Instagram.

Company Citizenship is a top priority for the company, which aspires to responsible and conscious expansion strategies when it comes to new recruitments and hiring, based on trust, transparency and accountability. The cornerstone of the company commitment towards its people is to always support competent and talents employees, building on their skills for better tomorrow.